Similar articles

• [PPI plus bismuth-based quintuple therapy].

  Kimura K, Hiratsuka T, Tamura K, Hiratsuka H, Suzuki T, Bray R. Kimura K, et al. Nihon Rinsho. 2005 Nov;63 Suppl 11:452-8. Nihon Rinsho. 2005. PMID: 16363577 Clinical Trial. Japanese. No abstract available.
• Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.

  Fennerty MB. Fennerty MB. Am J Gastroenterol. 1998 Jan;93(1):2-3. doi: 10.1111/j.1572-0241.1998.002_c.x. Am J Gastroenterol. 1998. PMID: 9448162 Clinical Trial. No abstract available.
• Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.

  Laine L, Estrada R, Trujillo M, Emami S. Laine L, et al. Am J Gastroenterol. 1997 Dec;92(12):2213-5. Am J Gastroenterol. 1997. PMID: 9399755 Clinical Trial.
• Pylera for the eradication of Helicobacter pylori infection.

  Saleem A, Qasim A, O'Connor HJ, O'Morain CA. Saleem A, et al. Expert Rev Anti Infect Ther. 2009 Sep;7(7):793-9. doi: 10.1586/eri.09.55. Expert Rev Anti Infect Ther. 2009. PMID: 19735221 Review.
• [Treatment of Helicobacter pylori infections].

  Calvet Calvo X. Calvet Calvo X. Gastroenterol Hepatol. 1998 Apr;21(4):203-6. Gastroenterol Hepatol. 1998. PMID: 9633184 Review. Spanish. No abstract available.